Syapse, a provider of software for the healthcare field, has raised $10 million in Series B financing led by Safeguard Scientifics (NYSE: SFE), with participation from previous investor The Social+Capital Partnership. Syapse's Precision Medicine Data Platform integrates complex genomic and clinical data with care pathways and medical knowledge bases, providing clinicians with actionable insights to enable diagnosis and treatment. The platform integrates data from electronic medical records, molecular testing labs and imaging and billing systems; it is agnostic to the data source or system. Syapse will use proceeds from the round to expand sales, marketing and client services, as well as further accelerate product development. The new capital brings the company's total funding to $14.5 million.